Magnis Resources Limited (ASX: MNS) – Stride to strengthening position

magnis resources generic

Magnis Resources (ASX:MNS) has made significant progress in strengthening the company’s position with multiple battery plants throughout the world and as a leading manufacturer of lithium-ion batteries. Installment of equipment and development of the company’s 44% owned battery plant in New York is on track and given the progress made it is attracting considerable interest from new investors. Magnis owns 33% of the Townsville battery plant and recent support by the Queensland State Government has also generated more investor interest in the Company.

To add to the three plants planned in Australia, the United States and Germany, Magnis and its technology partner Charge CCCV(C4V), have been exploring opportunities to develop battery plants in other countries. Magnis and C4V have the skills and capacity to continue developing new plants which is a key growth pillar for the Company. The Company is planning a regional office which will be staffed by experienced sector professionals, for Magnis to attract added interest from potential investors and industry groups.

Magnis is trading at a current market price of $0.370 as at July 24, 2018 (before market close) and has seen a decline or a performance change of -8.54% over the past 12 months.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report